Loading organizations...
Key people at Capital Croissance.
Capital Croissance operates as an independent investment management firm, providing equity capital to fast-growing startups and small-to-medium-sized enterprises across diverse sectors. The firm partners directly with entrepreneurs and families, offering investments typically ranging from €500k to €50m to fuel ambitious development projects.
Established in 2012, Capital Croissance was founded by Eric Neuplanche and other partners. Their insight was to cultivate a unique club of entrepreneurs dedicated to investing in and actively supporting growth companies. This model leverages the collective experience and extensive networks of its entrepreneurial team for collaborative partnership.
Capital Croissance primarily serves entrepreneurs and families leading dynamic growth businesses. The firm’s vision centers on fostering a robust, network-driven investment ecosystem, where over 500 entrepreneur-investors contribute expertise and connections. They maintain a strong commitment to ethical practices and social responsibility, aiming for long-term value creation.
Key people at Capital Croissance.
Capital Croissance has 1 tracked investment across 1 company. The latest tracked deal is $8.0M Series A in Promethera Biosciences in November 2009.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Nov 9, 2009 | Promethera Biosciences | $8.0M Series A | Vesalius Biocapital | Life Sciences Research Partners, LRM, Nivelinvest, Sopartec, Sriw, Vives Louvain Technology Fund |